Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Affordable and Safe Prescription Drug Importation Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act Implementation of FDA Reauthorization Act of 2017
Affordable and Safe Prescription Drug Importation Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act Implementation of FDA Reauthorization Act of 2017
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SPARK THERAPEUTICS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · 3A
Issues related to the development of therapies for rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSPERITY SERVICES, L.P. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · 3A
Source: Senate LDA
| UNIVERSITY OF UTAH |
| 18 |
| 2012–2016 |
| ABBOTT LABORATORIES | 16 | 2011–2014 |
| SIGNATURE MEDICAL GROUP, INC. | 16 | 2014–2017 |
| Vivus, Inc. | 15 | 2009–2013 |
| COMPLETE PHARMA HOLDINGS LLC | 14 | 2014–2017 |
| WALGREEN CO | 13 | 2015–2018 |
| ARDENT HEALTH SERVICES | 12 | 2013–2018 |
| COALITION FOR PATIENT VISION CARE SAFETY | 11 | 2015–2017 |
| LIFEPOINT HEALTH | 11 | 2016–2018 |
| QUESTCOR PHARMACEUTICALS | 11 | 2009–2014 |
| BRENTWOOD SCHOOL | 9 | 2014–2016 |
| INSPERITY SERVICES, L.P. | 9 | 2017–2018 |
| VIRTUSTREAM, INC. | 9 | 2016–2017 |
| BORREGO HEALTH | 8 | 2017–2018 |
| MPM HOLDINGS INC. | 8 | 2011–2012 |
| NMAC (ON BEHALF OF THE HIV/STD PARTNERSHIP) | 8 | 2017–2018 |
| MUNICIPALITY OF PONCE | 7 | 2013–2015 |
| GENOMIND | 6 | 2016–2017 |
| GLOBAL DOWN SYNDROME FOUNDATION (FORMERLY REPORTING AS AJS VENTURES LLC) | 6 | 2011–2012 |
| KANSAS CITY UNIVERSITY OF MEDICINE AND BIOSCIENCES | 6 | 2016–2017 |
| MED-CARE DIABETIC AND MEDICAL SUPPLIES, INC. | 6 | 2014–2015 |
| SPARK THERAPEUTICS, INC. | 6 | 2017–2018 |
| AMERICAN INDIAN HEALTH & SERVICES | 5 | 2017–2018 |
| ANTHEM, INC. | 5 | 2017–2018 |
| AMFAR THE FOUNDATION FOR AIDS RESEARCH | 4 | 2018 |
| AMPLIFON (USA), INC. | 4 | 2016 |
| BAXALTA INC. | 4 | 2015–2016 |
| GIRL SCOUTS OF THE USA | 4 | 2012 |
| INTERTEK TESTING SERVICES NA, INC. | 4 | 2012–2013 |
| OFFICE OF THE GOVERNOR, STATE OF COLORADO | 4 | 2017–2018 |
| VERDANT HOLDINGS LLC | 4 | 2018 |
| VIIAD SYSTEMS, LLC | 4 | 2014–2015 |
| AMGEN USA, INC. | 3 | 2018 |
| BRUNO INDEPENDENT LIVING AIDS INC | 3 | 2018 |
| DAVITA INC. | 3 | 2011 |
| HARMONY BIOSCIENCES | 3 | 2018 |
| HYGREEN, INC | 3 | 2012 |
| MASIMO CORPORATION | 3 | 2009–2010 |
| MOBILE MEDICAL INTERNATIONAL CORPORATION (MMIC) | 3 | 2010 |
| NOVARTIS | 3 | 2017 |
| SAFE RX | 3 | 2016 |
| SYMPLICITY CORPORATION | 3 | 2014–2015 |
| THE FEDERATION OF STATE MEDICAL BOARDS | 3 | 2018 |
| NATIONAL FEDERATION OF THE BLIND | 2 | 2017 |
| SENTRILLION | 2 | 2011–2012 |
| Z-MEDICA CORPORATION | 2 | 2010–2011 |
| ZOLL DATA SYSTEMS | 2 | 2010 |
| APPLICATION DEVELOPERS ALLIANCE | 1 | 2013 |
| PROPERTY CASUALTY INSURERS ASSOCIATION OF AMERICA | 1 | 2011 |
Affordable and Safe Prescription Drug Importation Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act Implementation of FDA Reauthorization Act of 2017
Pharmacy and Medically Underserved Areas Enhancement Act
Client: WALGREEN CO. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act Opioid disposal S.109 - Pharmacy and Medically Underserved Areas Enhancement Act Provider status for medicaid reimbursement
Pharmacy and Medically Underserved Areas Enhancement Act
Client: WALGREEN CO. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act Opioid disposal S.109 - Pharmacy and Medically Underserved Areas Enhancement Act Provider status for medicaid reimbursement
Pharmacy and Medically Underserved Areas Enhancement Act
Client: WALGREEN CO. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act Opioid disposal S.109 - Pharmacy and Medically Underserved Areas Enhancement Act Provider status for medicaid reimbursement
Expressing support for the designation of March 3, 2018, as World Hearing Day.
Client: INTERNATIONAL HEARING SOCIETY · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to OTC hearing aids H. Res 740 - Expressing support for the designation of March 3, 2018, as World Hearing Day
Expressing support for the designation of March 3, 2018, as World Hearing Day.
Client: INTERNATIONAL HEARING SOCIETY · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to OTC hearing aids H. Res 740 - Expressing support for the designation of March 3, 2018, as World Hearing Day
Expressing support for the designation of March 3, 2018, as World Hearing Day.
Client: INTERNATIONAL HEARING SOCIETY · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to OTC hearing aids H. Res 740 - Expressing support for the designation of March 3, 2018, as World Hearing Day
Expressing support for the designation of March 3, 2018, as World Hearing Day.
Client: INTERNATIONAL HEARING SOCIETY · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to OTC hearing aids H. Res 740 - Expressing support for the designation of March 3, 2018, as World Hearing Day
Pharmacy and Medically Underserved Areas Enhancement Act
Client: WALGREEN CO. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act Opioid disposal S.109 - Pharmacy and Medically Underserved Areas Enhancement Act Provider status for medicaid reimbursement
Pharmacy and Medically Underserved Areas Enhancement Act
Client: WALGREEN CO. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act Opioid disposal S.109 - Pharmacy and Medically Underserved Areas Enhancement Act Provider status for medicaid reimbursement
Pharmacy and Medically Underserved Areas Enhancement Act
Client: WALGREEN CO. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act Opioid disposal S.109 - Pharmacy and Medically Underserved Areas Enhancement Act Provider status for medicaid reimbursement
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: INSPERITY SERVICES, L.P. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to tax reform H.R. 1 (PL 115-97)
Patient Access to Higher Quality Health Care Act of 2017
Client: SIGNATURE MEDICAL GROUP, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R. 1156 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark exemptions Comprehensive join replacements Medicare Access and CHIP Reauthorization Act
Patient Access to Higher Quality Health Care Act of 2017
Client: SIGNATURE MEDICAL GROUP, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals Issues related to computed radiography
Patient Access to Higher Quality Health Care Act of 2017
Client: SIGNATURE MEDICAL GROUP, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals Issues related to computed radiography H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Patient Access to Higher Quality Health Care Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Patient Access to Higher Quality Health Care Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals
Patient Access to Higher Quality Health Care Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Patient Access to Higher Quality Health Care Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals
Patient Access to Higher Quality Health Care Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Patient Access to Higher Quality Health Care Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive join replacements Medicare Access and CHIP Reauthorization Act
Patient Access to Higher Quality Health Care Act of 2017
Client: SIGNATURE MEDICAL GROUP, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals Issues related to computed radiography
Affordable and Safe Prescription Drug Importation Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act Implementation of FDA Reauthorization Act of 2017
Affordable and Safe Prescription Drug Importation Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act S. 934/H.R. 2430 - FDA Reauthorization Act of 2017
Affordable and Safe Prescription Drug Importation Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act S. 934/H.R. 2430 - FDA Reauthorization Act of 2017
Affordable and Safe Prescription Drug Importation Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act Implementation of FDA Reauthorization Act of 2017
Affordable and Safe Prescription Drug Importation Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act
Affordable and Safe Prescription Drug Importation Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act S. 934/H.R. 2430 - FDA Reauthorization Act of 2017
DXM Abuse Prevention Act of 2017
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Dextromethorphan Legislation related to reducing incidents of abuse of a common ingredient in over-the-counter cough and cold medications H.R. 1271 - DXM Abuse Prevention Act of 2017
DXM Abuse Prevention Act of 2017
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Dextromethorphan Legislation related to reducing incidents of abuse of a common ingredient in over-the-counter cough and cold medications H.R. 1271 - DXM Abuse Prevention Act of 2017
DXM Abuse Prevention Act of 2017
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Dextromethorphan Legislation related to reducing incidents of abuse of a common ingredient in over-the-counter cough and cold medications H.R. 1271 - DXM Abuse Prevention Act of 2017
DXM Abuse Prevention Act of 2017
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Dextromethorphan Legislation related to reducing incidents of abuse of a common ingredient in over-the-counter cough and cold medications H.R. 1271 - DXM Abuse Prevention Act of 2017
Transitioning to Integrated and Meaningful Employment Act of 2017
Client: NATIONAL FEDERATION OF THE BLIND · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 1377 - Transitioning to Integrated and Meaningful Employment Act of 2017 (TIME Act)
American Health Care Act of 2017
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 1628 - American Health Care Act of 2017 Issues related to testing and treatment of Hepatitis Biosimilars FDA reform Implementation of the 21st Century Cures Act 340B Program Issues related to patient access
American Health Care Act of 2017
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 1628 - American Health Care Act of 2017 Issues related to testing and treatment of Hepatitis Biosimilars FDA reform Implementation of the 21st Century Cures Act 340B Program Issues related to patient access
Access Technology Affordability Act of 2017
Client: NATIONAL FEDERATION OF THE BLIND · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 1734/S. 732 - Access Technology Affordability Act of 2017
FDA Reauthorization Act of 2017
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act S. 934/H.R. 2430 - FDA Reauthorization Act of 2017
FDA Reauthorization Act of 2017
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act S. 934/H.R. 2430 - FDA Reauthorization Act of 2017
FDA Reauthorization Act of 2017
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act S. 934/H.R. 2430 - FDA Reauthorization Act of 2017
Restoring Access to Medication Act of 2017
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to utilization of HSA and FSA H.R. 394/S. 85 - Restoring Access to Medication Act
Restoring Access to Medication Act of 2017
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to utilization of HSA and FSA H.R. 394/S. 85 - Restoring Access to Medication Act
Restoring Access to Medication Act of 2017
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to utilization of HSA and FSA H.R. 394/S. 85 - Restoring Access to Medication Act
Restoring Access to Medication Act of 2017
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to utilization of HSA and FSA H.R. 394/S. 85 - Restoring Access to Medication Act
Medicare Care Coordination Improvement Act of 2017
Client: SIGNATURE MEDICAL GROUP, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals Issues related to computed radiography H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Medicare Care Coordination Improvement Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Medicare Care Coordination Improvement Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Medicare Care Coordination Improvement Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Pharmacy and Medically Underserved Areas Enhancement Act
Client: WALGREEN CO. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Pharmacy and Medically Underserved Areas Enhancement Act
Client: WALGREEN CO. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Pharmacy and Medically Underserved Areas Enhancement Act
Client: WALGREEN CO. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Pharmacy and Medically Underserved Areas Enhancement Act
Client: WALGREEN CO. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Patient Access to Higher Quality Health Care Act of 2017
Client: SIGNATURE MEDICAL GROUP, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals Issues related to computed radiography
Patient Access to Higher Quality Health Care Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Patient Access to Higher Quality Health Care Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Patient Access to Higher Quality Health Care Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals
Patient Access to Higher Quality Health Care Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Patient Access to Higher Quality Health Care Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals
Patient Access to Higher Quality Health Care Act of 2017
Client: SIGNATURE MEDICAL GROUP, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals Issues related to computed radiography H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Patient Access to Higher Quality Health Care Act of 2017
Client: SIGNATURE MEDICAL GROUP, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals Issues related to computed radiography
Medicare Care Coordination Improvement Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Medicare Care Coordination Improvement Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Medicare Care Coordination Improvement Act of 2017
Client: SIGNATURE MEDICAL GROUP, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals Issues related to computed radiography H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Medicare Care Coordination Improvement Act of 2017
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Access Technology Affordability Act of 2017
Client: NATIONAL FEDERATION OF THE BLIND · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 1734/S. 732 - Access Technology Affordability Act of 2017
Restoring Access to Medication Act of 2017
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to utilization of HSA and FSA H.R. 394/S. 85 - Restoring Access to Medication Act
Restoring Access to Medication Act of 2017
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to utilization of HSA and FSA H.R. 394/S. 85 - Restoring Access to Medication Act
Restoring Access to Medication Act of 2017
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to utilization of HSA and FSA H.R. 394/S. 85 - Restoring Access to Medication Act
Restoring Access to Medication Act of 2017
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to utilization of HSA and FSA H.R. 394/S. 85 - Restoring Access to Medication Act
FDA Reauthorization Act of 2017
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act S. 934/H.R. 2430 - FDA Reauthorization Act of 2017
FDA Reauthorization Act of 2017
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act S. 934/H.R. 2430 - FDA Reauthorization Act of 2017
FDA Reauthorization Act of 2017
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act S. 934/H.R. 2430 - FDA Reauthorization Act of 2017
Viral Hepatitis Testing Act of 2015
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 1101 - Viral Hepatitis Testing Act S. 1287 - Viral Hepatitis Testing Act Issues related to testing and treatment of Hepatitis Biosimilars FDA Reform 21st Century Cures 340B Program Issues related to patient access
Viral Hepatitis Testing Act of 2015
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 1101 - Viral Hepatitis Testing Act S. 1287 - Viral Hepatitis Testing Act Issues related to testing and treatment of Hepatitis Biosimilars FDA Reform 21st Century Cures 340B Program Issues related to patient access
Viral Hepatitis Testing Act of 2015
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 1101 - Viral Hepatitis Testing Act S. 1287 - Viral Hepatitis Testing Act Issues related to testing and treatment of Hepatitis Biosimilars FDA Reform 21st Century Cures 340B Program Issues related to patient access
Viral Hepatitis Testing Act of 2015
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 1101 - Viral Hepatitis Testing Act S. 1287 - Viral Hepatitis Testing Act Issues related to testing and treatment of Hepatitis Biosimilars FDA Reform 21st Century Cures 340B Program Issues related to patient access
Viral Hepatitis Testing Act of 2015
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 1101 - Viral Hepatitis Testing Act S. 1287 - Viral Hepatitis Testing Act Issues related to testing and treatment of Hepatitis Biosimilars FDA Reform 21st Century Cures 340B Program Issues related to patient access
Viral Hepatitis Testing Act of 2015
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 1101 - Viral Hepatitis Testing Act S. 1287 - Viral Hepatitis Testing Act Issues related to testing and treatment of Hepatitis Biosimilars FDA Reform 21st Century Cures 340B Program Issues related to patient access
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis H.R. 1130/S.598 - The Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 FDA Reform - 21st Century Cures Act Availability of medical products
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis H.R. 1130/S.598 - The Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 FDA Reform Availability of medical products
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis H.R. 1130/S.598 - The Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 FDA Reform Availability of medical products
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Healthcare reform In-home dialysis H.R. 1130/S.598 - The Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 FDA Reform Availability of medical products
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S.709 - Restoring Access to Medication Act H.R.1270 - Restoring Access to Medication Act
Promoting Access, Competition, and Equity Act of 2015
Client: SIGNATURE MEDICAL GROUP, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R.2513 - PACE Act of 2015 Issues related to Stark exemptions Comprehensive joint replacements
Promoting Access, Competition, and Equity Act of 2015
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R.2513 - PACE Act of 2015 Issues related to Stark exemptions Comprehensive joint replacements
Promoting Access, Competition, and Equity Act of 2015
Client: SIGNATURE MEDICAL GROUP, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R.2513 - PACE Act of 2015 Issues related to Stark exemptions Comprehensive joint replacements
Promoting Access, Competition, and Equity Act of 2015
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative, comprehensive joint replacements H.R.2513 - PACE Act of 2015 Issues related to Stark exemptions Comprehensive joint replacements Medicare and CHIP Reauthorization Act H.R. 5273 - Helping Hospitals Improve Patient Care Act of 2016
Promoting Access, Competition, and Equity Act of 2015
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative, comprehensive joint replacements H.R.2513 - PACE Act of 2015 Issues related to Stark exemptions Comprehensive joint replacements Medicare and CHIP Reauthorization Act H.R. 5273 - Helping Hospitals Improve Patient Care Act of 2016
Promoting Access, Competition, and Equity Act of 2015
Client: THE ORTHOFORUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative, comprehensive joint replacements H.R.2513 - PACE Act of 2015 Issues related to Stark exemptions Comprehensive joint replacements Medicare and CHIP Reauthorization Act H.R. 5273 - Helping Hospitals Improve Patient Care Act of 2016
Promoting Access, Competition, and Equity Act of 2015
Client: SIGNATURE MEDICAL GROUP, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R.2513 - PACE Act of 2015 Issues related to Stark exemptions Comprehensive joint replacements
Promoting Access, Competition, and Equity Act of 2015
Client: SIGNATURE MEDICAL GROUP, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R.2513 - PACE Act of 2015 Issues related to Stark exemptions Comprehensive joint replacements
Veterans Mobility Safety Act of 2016
Client: INTERNATIONAL HEARING SOCIETY · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Work with the Veterans Administration to help address veterans' hearing health care needs S.546/H.R.3471 - A bill to amend title 38, United States Code, to include licensed hearing aid specialists as eligible for appointment in the Veterans Health Administration
Veterans Mobility Safety Act of 2016
Client: INTERNATIONAL HEARING SOCIETY · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Work with the Veterans Administration to help address veterans' hearing health care needs S.546/H.R.3471 - A bill to amend title 38, United States Code, to include licensed hearing aid specialists as eligible for appointment in the Veterans Health Administration H.R. 5620 - VA Accountability First and Appeals Modernization Act of 2016
Veterans Mobility Safety Act of 2016
Client: INTERNATIONAL HEARING SOCIETY · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Work with the Veterans Administration to help address veterans' hearing health care needs S.546/H.R.3471 - A bill to amend title 38, United States Code, to include licensed hearing aid specialists as eligible for appointment in the Veterans Health Administration H.R. 5620 - VA Accountability First and Appeals Modernization Act of 2016
Veterans' Access to Hearing Health Act of 2015
Client: INTERNATIONAL HEARING SOCIETY · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Work with the Veterans Administration to help address veterans' hearing health care needs S.546/H.R.353 - A bill to amend title 38, United States Code, to include licensed hearing aid specialists as eligible for appointment in the Veterans Health Administration
National Defense Authorization Act for Fiscal Year 2017
Client: SAFE RX · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 (PL 114-328) Comprehensive Addiction and Recovery Act of 2016 - Title VII, Section 746 Department of Defense Study on preventing the diversion of opiod medications S. 2943/H.R. 4909 (PL 114-198) National Defense Authorization Act for fiscal year 2017 - Title III, Section 301 Evidence based prescription opiod and heroin treatment and interventions demonstration
Issues related to healthcare Department of Labor regulations
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, White House Office
VERDANT HOLDINGS LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Rehabilitation issues related to the creation of a health and wellness campus for veterans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
BRUNO INDEPENDENT LIVING AIDS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to mobility devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
WALGREEN CO. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to Veterans access to immunizations
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act Opioid disposal S.109 - Pharmacy and Medically Underserved Areas Enhancement Act Provider status for medicaid reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Council of Economic Advisers (CEA), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Economic Council (NEC), SENATE, State, Dept of (DOS), Treasury, Dept of, Vice President of the U.S.
THE FEDERATION OF STATE MEDICAL BOARDS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Anti-trust issues related to the licensure of physicians, telemedicine, and state medical boards
Issues related to the licensure of physicians, telemedicine, and state medical boards
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPARK THERAPEUTICS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to the development of therapies for rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFEPOINT HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to hospital reimbursement Issues related to charity care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NMAC (ON BEHALF OF THE HIV/STD PARTNERSHIP) via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to the HIV/STD community Viral hepatitis funding Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to pseudoephedrine Issues related to the regulation of cosmetic products Safe use of OTC products Matters related to American Medical Association Resolution 208(A-16) adopted April 2016
Issues related to 340B drug discount program
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
INSPERITY SERVICES, L.P. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to healthcare Department of Labor regulations
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, White House Office
INTERNATIONAL HEARING SOCIETY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to OTC hearing aids H. Res 740 - Expressing support for the designation of March 3, 2018, as World Hearing Day
Work with the VA to help address veterans' hearing health care needs
Issues related to pass-throughs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA)
HARMONY BIOSCIENCES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to the development of therapies for rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BORREGO HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
BAXTER HEALTHCARE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement
Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act Implementation of FDA Reauthorization Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to testing and treatment of Hepatitis Biosimilars FDA reform Implementation of the 21st Century Cures Act 340B Program Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform Medicare Part D
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
ANTHEM, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to CSRs and health insurance Federal budget issue Health insurance tax and general tax issues
Issues related to opioids
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Pension Benefit Guaranty Corporation (PBGC), SENATE, Treasury, Dept of
AMERICAN INDIAN HEALTH & SERVICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · 3T
Issues related to potential property acquisition
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ARDENT HEALTH SERVICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to Medicaid
AMGEN USA INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to the 340B Drug Discount Program Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMFAR THE FOUNDATION FOR AIDS RESEARCH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · third_quarter · Q3
Issues related to HIV/AIDS, expanded access to HIV prevention and treatment services, syringe exchange programs, issues related to the opioid epidemic, hepatitis C, and access to care
HIV/AIDS funding issues
Issues related to President's Emergency Plan for AIDS Relief (PEPFAR), Global Fund and global health programs
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · 2A
Issues related to pseudoephedrine Issues related to the regulation of cosmetic products Safe use of OTC products Matters related to American Medical Association Resolution 208(A-16) adopted April 2016
Issues related to 340B drug discount program
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERDANT HOLDINGS LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · RA
Rehabilitation issues related to the creation of a health and wellness campus for veterans
INTERNATIONAL HEARING SOCIETY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · 1A
Work with the VA to help address veterans' hearing health care needs
Issues related to OTC hearing aids H. Res 740 - Expressing support for the designation of March 3, 2018, as World Hearing Day
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
VERDANT HOLDINGS LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Rehabilitation issues related to the creation of a health and wellness campus for veterans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
BRUNO INDEPENDENT LIVING AIDS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to mobility devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
WALGREEN CO. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to Medicaid security
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act Opioid disposal S.109 - Pharmacy and Medically Underserved Areas Enhancement Act Provider status for medicaid reimbursement
Issues related to Veterans access to immunizations
LIFEPOINT HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to hospital reimbursement Issues related to charity care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL HEARING SOCIETY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to OTC hearing aids H. Res 740 - Expressing support for the designation of March 3, 2018, as World Hearing Day
Issues related to pass-throughs
Work with the VA to help address veterans' hearing health care needs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA)
ANTHEM, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to CSRs and health insurance Federal budget issue Health insurance tax and general tax issues
Issues related to opioids
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMFAR THE FOUNDATION FOR AIDS RESEARCH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
HIV/AIDS funding issues
Issues related to HIV/AIDS, expanded access to HIV prevention and treatment services, syringe exchange programs, issues related to the opioid epidemic, hepatitis C, and access to care
Issues related to President's Emergency Plan for AIDS Relief (PEPFAR), Global Fund and global health programs
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE FEDERATION OF STATE MEDICAL BOARDS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to the licensure of physicians, telemedicine, and state medical boards
Issues related to the licensure of physicians, telemedicine, and state medical boards
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to pseudoephedrine Issues related to the regulation of cosmetic products Safe use of OTC products Matters related to American Medical Association Resolution 208(A-16) adopted April 2016
Issues related to 340B drug discount program
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BORREGO HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to testing and treatment of Hepatitis Biosimilars FDA reform Implementation of the 21st Century Cures Act 340B Program Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform Medicare Part D
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
AMGEN USA INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to the 340B Drug Discount Program Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSPERITY SERVICES, L.P. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to healthcare Department of Labor regulations
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, White House Office
HARMONY BIOSCIENCES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to the development of therapies for rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPARK THERAPEUTICS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to the development of therapies for rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NMAC (ON BEHALF OF THE HIV/STD PARTNERSHIP) via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to the HIV/STD community Viral hepatitis funding
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAXTER HEALTHCARE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act Implementation of FDA Reauthorization Act of 2017
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARDENT HEALTH SERVICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to Medicaid
AMERICAN INDIAN HEALTH & SERVICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · Q2
Issues related to potential property acquisition
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERDANT HOLDINGS LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · RR
Rehabilitation issues related to the creation of a health and wellness campus for veterans
HARMONY BIOSCIENCES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · RR
Healthcare issues
AMGEN USA INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · RR
Issues related to the 340B Drug Discount Program
BRUNO INDEPENDENT LIVING AIDS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · RR
Issues related to mobility devices
THE FEDERATION OF STATE MEDICAL BOARDS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · second_quarter · RR
Issues related to the licensure of physicians, telemedicine, and state medical boards
BORREGO HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Issues related to Medicaid
Issues related to Teaching Health Centers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARDENT HEALTH SERVICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Issues related to Medicaid
WALGREEN CO. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Issues related to Veterans access to immunizations
Issues related to the proposed transaction between Walgreens Boots Alliance and Rite Aid
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act Opioid disposal S.109 - Pharmacy and Medically Underserved Areas Enhancement Act Provider status for medicaid reimbursement
SPARK THERAPEUTICS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Issues related to the development of therapies for rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Issues related to testing and treatment of Hepatitis Biosimilars FDA reform Implementation of the 21st Century Cures Act 340B Program Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform
Implementation of the Military Construction and Veterans Affairs and Related Agencies Appropriations for FY18
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Issues related to 340B drug discount program Issues related to FDA user fees and ACA repeal/replace
Issues related to pseudoephedrine Issues related to the regulation of cosmetic products Safe use of OTC products Matters related to American Medical Association Resolution 208(A-16) adopted April 2016
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INSPERITY SERVICES, L.P. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Issues related to healthcare Department of Labor regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFEPOINT HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Issues related to hospital reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OFFICE OF THE GOVERNOR, STATE OF COLORADO via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · 1T
Issues related to health care
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), SENATE, Transportation, Dept of (DOT)
NMAC (ON BEHALF OF THE HIV/STD PARTNERSHIP) via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Issues related to the HIV/STD community Viral hepatitis funding
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERNATIONAL HEARING SOCIETY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Issues related to OTC hearing aids H. Res 740 - Expressing support for the designation of March 3, 2018, as World Hearing Day
Work with the VA to help address veterans' hearing health care needs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
BAXTER HEALTHCARE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act Implementation of FDA Reauthorization Act of 2017
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTHEM, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Issues related to opioids
Issues related to CSRs and health insurance Federal budget issue
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN INDIAN HEALTH & SERVICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Issues related to potential property acquisition
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMFAR THE FOUNDATION FOR AIDS RESEARCH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · Q1
Issues related to President's Emergency Plan for AIDS Relief (PEPFAR), Global Fund and global health programs
Issues related to HIV/AIDS, expanded access to HIV prevention and treatment services, syringe exchange programs, issues related to the opioid epidemic, hepatitis C, and access to care
HIV/AIDS funding issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMFAR THE FOUNDATION FOR AIDS RESEARCH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2018 · first_quarter · RR
HIV/AIDS funding issues; Issues related to President's Emergency Plan for AIDS Relief (PEPFAR), Global Fund and global health programs; Issues related to HIV/AIDS, expanded access to HIV prevention and treatment services, syringe exchange programs, issues related to the opioid epidemic, hepatitis C, and access to care
HIV/AIDS funding issues; Issues related to President's Emergency Plan for AIDS Relief (PEPFAR), Global Fund and global health programs; Issues related to HIV/AIDS, expanded access to HIV prevention and treatment services, syringe exchange programs, issues related to the opioid epidemic, hepatitis C, and access to care
THE ORTHOFORUM via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · 4A
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAXTER HEALTHCARE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · third_quarter · 3A
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act S. 934/H.R. 2430 - FDA Reauthorization Act of 2017
Funding issues for Medicare Part B 340 B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · 4A
Issues related to pseudoephedrine Issues related to the regulation of cosmetic products Safe use of OTC products Matters related to American Medical Association Resolution 208(A-16) adopted April 2016
Issues related to 340B drug discount program Issues related to FDA user fees and ACA repeal/replace
Issues related to Veteran Suicide Prevention
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE ORTHOFORUM via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · 4A
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAXTER HEALTHCARE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · 4A
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act Implementation of FDA Reauthorization Act of 2017
Funding issues for Medicare Part B 340 B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · 4A
Issues related to Veteran Suicide Prevention
Issues related to pseudoephedrine Issues related to the regulation of cosmetic products Safe use of OTC products Matters related to American Medical Association Resolution 208(A-16) adopted April 2016
Issues related to 340B drug discount program Issues related to FDA user fees and ACA repeal/replace
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR PATIENT VISION CARE SAFETY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Draft Fairness to Contact Lens Consumer Act 2004 Contact Lens Rule Review Issues related to the regulation of the contact lens marketplace
Draft Fairness to Contact Lens Consumer Act 2004 Contact Lens Rule Review Issues related to contacts lens patient safety
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
SPARK THERAPEUTICS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues related to the development of therapies for rare diseases
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues related to Puerto Rico
Issues related to testing and treatment of Hepatitis Biosimilars FDA reform Implementation of the 21st Century Cures Act 340B Program Issues related to patient access Issues related to pharmaceutical manufacturing
Implementation of the Military Construction and Veterans Affairs and Related Agencies Appropriations Act of 2017 Appropriations for FY18
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA)
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues related to 340B drug discount program Issues related to FDA user fees and ACA repeal/replace
Issues related to pseudoephedrine Issues related to the regulation of cosmetic products Safe use of OTC products Matters related to American Medical Association Resolution 208(A-16) adopted April 2016
Issues related to Veteran Suicide Prevention
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SIGNATURE MEDICAL GROUP, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals Issues related to computed radiography H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE ORTHOFORUM via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals H.R. 4206/S. 2051 - Medicare Care Coordination Improvement Act of 2017
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WALGREEN CO. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues related to the proposed transaction between Walgreens Boots Alliance and Rite Aid
Issues related to Medicaid security
Issues related to Veterans access to immunizations
LIFEPOINT HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues related to hospital reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OFFICE OF THE GOVERNOR, STATE OF COLORADO via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues related to health care
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), SENATE, Transportation, Dept of (DOT)
NMAC (ON BEHALF OF THE HIV/STD PARTNERSHIP) via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues related to the HIV/STD community
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), SENATE
INTERNATIONAL HEARING SOCIETY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues related to OTC hearing aids
Work with the VA to help address veterans' hearing health care needs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
INSPERITY SERVICES, L.P. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues related to healthcare
Issues related to tax reform H.R. 1 (PL 115-97)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · 4T
Preserving consumer access to over-the-counter medicines containing pseudoephedrine Rx-to-OTC switch Issues related to monograph reform
Dextromethorphan Legislation related to reducing incidents of abuse of a common ingredient in over-the-counter cough and cold medications H.R. 1271 - DXM Abuse Prevention Act of 2017
Issues related to utilization of HSA and FSA H.R. 394/S. 85 - Restoring Access to Medication Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMPLETE PHARMA HOLDINGS LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · 4T
Pharmaceutical issues regarding rare diseases Drug pricing
BORREGO HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues related to contracting with the VA to provide health care services to veterans
Issues related to Teaching Health Centers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
BAXTER HEALTHCARE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Funding issues for Medicare Part B 340 B drug discount program
Healthcare reform In-home dialysis Telemedicine Availability of medical products H.R. 1245 - Affordable and Safe Prescription Drug Importation Act Implementation of FDA Reauthorization Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARDENT HEALTH SERVICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues related to Medicaid
ANTHEM, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues related to opioids
Issues related to CSRs and health insurance Federal budget issue
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN INDIAN HEALTH & SERVICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · Q4
Issues related to potential property acquisition
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN INDIAN HEALTH & SERVICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · RR
Issues related to potential property acquisition
SPARK THERAPEUTICS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · fourth_quarter · RR
Pharmaceutical Issues
THE ORTHOFORUM via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · third_quarter · Q3
Payment issues relating to orthopaedic practices that own in-office ancillary services Bundled Payments Initiative H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark Exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SIGNATURE MEDICAL GROUP, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · third_quarter · Q3
Issues involving bundled payments as they pertain to the Center for Medicare and Medicaid Innovation H.R. 1156/S. 1133 - Patient Access to Higher Quality Health Care Act of 2017 Issues related to Stark exemptions Comprehensive joint replacements Medicare Access and CHIP Reauthorization Act implementation Issues related to physician owned hospitals Issues related to computed radiography
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRTUSTREAM, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · third_quarter · Q3
Raising awareness of unique software solutions to assist the Department of Veteran Affairs and veterans in achieving more efficiency in scheduling medical appointments
Filing targets: SENATE, Veterans Affairs, Dept of (VA)
WALGREEN CO. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · third_quarter · Q3
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Issues related to Medicaid security
Issues related to the proposed transaction between Walgreens Boots Alliance and Rite Aid
OFFICE OF THE GOVERNOR, STATE OF COLORADO via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · third_quarter · Q3
Issues related to health care
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
NMAC (ON BEHALF OF THE HIV/STD PARTNERSHIP) via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · third_quarter · Q3
Issues related to the HIV/STD community
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · third_quarter · 3T
Issues related to health care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFEPOINT HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · third_quarter · Q3
Issues related to hospital reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2017 · third_quarter · Q3
Issues related to trade treaty legislation
Implementation of the Military Construction and Veterans Affairs and Related Agencies Appropriations Act of 2017 Appropriations for FY18
Issues related to testing and treatment of Hepatitis Biosimilars FDA reform Implementation of the 21st Century Cures Act 340B Program Issues related to patient access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Issues related to the proposed transaction between Walgreens Boots Alliance and Rite Aid
Filing targets: Centers For Medicare and Medicaid Services (CMS), Council of Economic Advisers (CEA), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Vice President of the U.S.
Issues related to Medicaid security
Filing targets: Centers For Medicare and Medicaid Services (CMS), Council of Economic Advisers (CEA), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, U.S. Customs & Border Protection, Vice President of the U.S.
HIV/AIDS funding issues; Issues related to President's Emergency Plan for AIDS Relief (PEPFAR), Global Fund and global health programs; Issues related to HIV/AIDS, expanded access to HIV prevention and treatment services, syringe exchange programs, issues related to the opioid epidemic, hepatitis C, and access to care
H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Bureau of Investigation (FBI), HOUSE OF REPRESENTATIVES, SENATE, U.S. Customs & Border Protection, Veterans Affairs, Dept of (VA), Vice President of the U.S.
Issues related to Veterans access to immunizations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Bureau of Investigation (FBI), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA), Vice President of the U.S.